Zolpidem tartrate and Device failure - a phase IV clinical study of FDA data

Summary:

Device failure is reported as a side effect among people who take Zolpidem tartrate (zolpidem tartrate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Ibuprofen, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Device failure when taking Zolpidem tartrate. It is created by eHealthMe based on reports of 31,142 people who have side effects when taking Zolpidem tartrate from the FDA, and is updated regularly.

What is Zolpidem tartrate?

Zolpidem tartrate has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 32,177 Zolpidem tartrate users. Check the latest studies of Zolpidem tartrate.

What is Device failure?

Device failure is found to be associated with 751 drugs and 761 conditions by eHealthMe. Check the latest studies of Device failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

31,142 people reported to have side effects when taking Zolpidem tartrate.
Among them, 12 people (0.04%) have Device failure.

Could Zolpidem tartrate cause Device failure?

Among these 12 people:

How long have people been on Zolpidem tartrate when they have Device failure? *

What is the gender of people who have Device failure when taking Zolpidem tartrate? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Device failure when taking Zolpidem tartrate? *

What are other drugs people take besides Zolpidem tartrate? *

What are other side effects people have besides Device failure? *

Headache (pain in head): 3 people, 25.00%
Pain: 3 people, 25.00%
Pain In Extremity: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Weakness: 3 people, 25.00%
Migraine (headache): 2 people, 16.67%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 16.67%
Intervertebral Disc Degeneration (spinal disc degeneration): 2 people, 16.67%
Intervertebral Disc Protrusion (spinal disc protrusion): 2 people, 16.67%
Kidney Stones: 2 people, 16.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 25.00%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 2 people, 16.67%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 16.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 16.67%
Pain: 1 person, 8.33%
Joint Pain: 1 person, 8.33%
Ill-Defined Disorder: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem tartrate and have Device failure?

- Check whether Device failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zolpidem tartrate:

Zolpidem tartrate (32,177 reports)

Device failure treatments and more:

Device failure (17,275 reports)

Browse all side effects of Zolpidem tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device failure:

Device failure (751 drugs)

Browse all the conditions that are associated with Device failure:

Device failure (761 conditions)

Related publications that referenced our studies

Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Zolpidem tartrate) and Zolpidem tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.